UBS AM’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.85M Buy
+86,889
New +$1.85M ﹤0.01% 2177
2024
Q2
Sell
-114,592
Closed -$474K 2874
2024
Q1
$474K Buy
114,592
+56,792
+98% +$235K ﹤0.01% 2303
2023
Q4
$151K Hold
57,800
﹤0.01% 2509
2023
Q3
$108K Buy
+57,800
New +$108K ﹤0.01% 2561